The Pershing Square Foundation has announced the 2026 Lotus Award (formerly the Ovarian Cancer Challenge Grant), a competitive funding program to accelerate breakthrough research in ovarian cancer. Each recipient will receive $250,000 per year for three years ($750,000 total) to pursue high-risk, high-reward science with potential for transformative impact. Applications for the 2026 Lotus Award are currently being accepted until Monday, February 2nd at 5:00pm ET. For over a decade, the Foundation has advanced health initiatives in New York City by funding pioneering cancer researchers through the Pershing Square Sohn…
Read MoreThe Pershing Square Foundation Launches Lotus Award in Women’s Ovarian Health
